RT Journal Article
T1 Role of biomarkers in early infectious complications after lung transplantation.
A1 Suberviola, Borja
A1 Rellan, Luzdivina
A1 Riera, Jordi
A1 Iranzo, Reyes
A1 Garcia Campos, Ascension
A1 Robles, Juan Carlos
A1 Vicente, Rosario
A1 Miñambres, Eduardo
A1 Santibanez, Miguel
AB Infections and primary graft dysfunction are devastating complications in the immediate postoperative period following lung transplantation. Nowadays, reliable diagnostic tools are not available. Biomarkers could improve early infection diagnosis. Multicentre prospective observational study that included all centres authorized to perform lung transplantation in Spain. Lung infection and/or primary graft dysfunction presentation during study period (first postoperative week) was determined. Biomarkers were measured on ICU admission and daily till ICU discharge or for the following 6 consecutive postoperative days. We included 233 patients. Median PCT levels were significantly lower in patients with no infection than in patients with Infection on all follow up days. PCT levels were similar for PGD grades 1 and 2 and increased significantly in grade 3. CRP levels were similar in all groups, and no significant differences were observed at any study time point. In the absence of PGD grade 3, PCT levels above median (0.50 ng/ml on admission or 1.17 ng/ml on day 1) were significantly associated with more than two- and three-fold increase in the risk of infection (adjusted Odds Ratio 2.37, 95% confidence interval 1.06 to 5.30 and 3.44, 95% confidence interval 1.52 to 7.78, respectively). In the absence of severe primary graft dysfunction, procalcitonin can be useful in detecting infections during the first postoperative week. PGD grade 3 significantly increases PCT levels and interferes with the capacity of PCT as a marker of infection. PCT was superior to CRP in the diagnosis of infection during the study period.
YR 2017
FD 2017-07-13
LK http://hdl.handle.net/10668/11402
UL http://hdl.handle.net/10668/11402
LA en
DS RISalud
RD Apr 19, 2025